Harming Leniolisib News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Harming Leniolisib. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Harming Leniolisib Today - Breaking & Trending Today

Pharming To Develop Leniolisib For Additional PIDs Beyond APDS; Phase 2 Trial To Initiate In Q2

Published: December 13, 2023

Dutch biopharmaceutical company Pharming Group N.V. (PHAR) announced Wednesday its plans to develop leniolisib for additional primary immunodeficiencies or PIDs beyond activated phosphoinositide 3-kinase delta syndrome or APDS.

Source: rttnews.com

Related Topics:

Beth Israel Lahey HealthMore Such Health NewsClinical Immunodeficiency ProgramPharming GroupDrug AdministrationPhase 2 TrialPrimary ImmunodeficienciesHarming Leniolisib